Humacyte (HUMA) Short Interest Ratio & Short Volume → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free HUMA Stock Alerts $7.27 -0.05 (-0.68%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Humacyte Short Interest DataCurrent Short Interest4,190,000 sharesPrevious Short Interest4,490,000 sharesChange Vs. Previous Month-6.68%Dollar Volume Sold Short$27.11 millionShort Interest Ratio2.4 Days to CoverLast Record DateMay 15, 2024Outstanding Shares119,080,000 sharesFloat Size90,320,000 sharesShort Percent of Float4.64%Today's Trading Volume1,542,191 sharesAverage Trading Volume1,559,062 sharesToday's Volume Vs. Average99% Short Selling Humacyte ? Sign up to receive the latest short interest report for Humacyte and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHUMA Short Interest Over TimeHUMA Days to Cover Over TimeHUMA Percentage of Float Shorted Over Time Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Humacyte Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20244,190,000 shares $27.11 million -6.7%4.6%2.4 $6.47 4/30/20244,490,000 shares $17.60 million +14.0%5.0%3.2 $3.92 4/15/20243,940,000 shares $11.31 million -1.0%4.4%3 $2.87 3/31/20243,980,000 shares $12.38 million +5.3%4.6%4.1 $3.11 3/15/20243,780,000 shares $12.25 million -36.5%4.5%4.3 $3.24 2/29/20245,950,000 shares $25.88 million -9.3%7.0%7.6 $4.35 Get the Latest News and Ratings for HUMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Humacyte and its competitors with MarketBeat's FREE daily newsletter. 2/15/20246,560,000 shares $29.26 million +7.0%8.8%12 $4.46 1/31/20246,130,000 shares $20.35 million No Change8.2%13 $3.32 1/15/20246,130,000 shares $16.24 million +1.7%8.2%13.7 $2.65 12/31/20236,030,000 shares $17.13 million +8.5%8.1%13.2 $2.84 12/15/20235,560,000 shares $17.18 million -5.3%7.4%12.4 $3.09 11/30/20235,870,000 shares $15.56 million -3.6%7.8%10.9 $2.65 11/15/20236,090,000 shares $15.23 million +10.7%8.1%10.4 $2.50 10/31/20235,500,000 shares $11.66 million +7.8%7.4%7.7 $2.12 10/15/20235,100,000 shares $13.16 million -4.3%6.8%7.7 $2.58 9/30/20235,330,000 shares $15.62 million +1.5%7.1%8.3 $2.93 9/15/20235,250,000 shares $16.98 million +38.2%7.0%7.8 $3.24 8/31/20233,800,000 shares $14.55 million +19.1%5.7%5.5 $3.83 8/15/20233,190,000 shares $14.29 million +6.3%4.9%5.1 $4.48 7/31/20233,000,000 shares $9.84 million No Change4.7%6.3 $3.28 7/15/20233,000,000 shares $9.09 million +2.4%4.7%6.6 $3.03 6/30/20232,930,000 shares $8.38 million -1.7%4.5%6.7 $2.86 6/15/20232,980,000 shares $9.98 million -31.0%5.4%7.8 $3.35 5/31/20234,320,000 shares $14.82 million -21.7%7.6%15.7 $3.43 5/15/20235,520,000 shares $22.00 million +5.8%10.2%21 $3.99 4/30/20235,220,000 shares $16.91 million +0.2%9.7%21.9 $3.24 4/15/20235,210,000 shares $16.93 million -1.0%9.6%23.2 $3.25 3/31/20235,260,000 shares $16.25 million +3.3%9.7%22.6 $3.09 3/15/20235,090,000 shares $14.51 million +2.2%9.4%19 $2.85 2/28/20234,980,000 shares $15.24 million +3.5%9.8%14.7 $3.06 2/15/20234,810,000 shares $15.34 million +7.1%9.4%14.5 $3.19 1/31/20234,490,000 shares $11.81 million +3.0%8.8%13 $2.63 1/15/20234,360,000 shares $10.90 million -4.2%8.6%11.8 $2.50 12/30/20224,550,000 shares $9.60 million +1.6%8.9%11.7 $2.11 12/15/20224,480,000 shares $11.65 million +1.8%8.6%11.4 $2.60 11/30/20224,400,000 shares $13.73 million -4.4%8.5%12.7 $3.12 11/15/20224,600,000 shares $13.66 million -19.3%8.9%12.6 $2.97 10/31/20225,700,000 shares $19.61 million -13.6%11.0%13.8 $3.44 10/15/20226,600,000 shares $20.79 million -17.7%12.7%16.5 $3.15 9/30/20228,020,000 shares $26.15 million +2.0%15.5%19.8 $3.26Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… 9/15/20227,860,000 shares $32.15 million -6.5%15.2%18.1 $4.09 8/31/20228,410,000 shares $30.70 million -5.9%16.7%20.1 $3.65 8/15/20228,940,000 shares $42.73 million +2.6%17.7%19.1 $4.78 7/31/20228,710,000 shares $30.31 million +5.5%17.3%19.7 $3.48 7/15/20228,260,000 shares $28.91 million +10.0%16.4%18.2 $3.50 6/30/20227,510,000 shares $24.11 million +1.6%14.9%16.4 $3.21 6/15/20227,390,000 shares $27.93 million -2.1%14.7%16.3 $3.78 5/31/20227,550,000 shares $41.00 million +21.2%15.0%18.2 $5.43 5/15/20226,230,000 shares $33.46 million +5.8%12.3%16.8 $5.37 4/30/20225,890,000 shares $41.70 million +3.9%11.7%17.4 $7.08 4/15/20225,670,000 shares $41.79 million +15.2%11.2%15.8 $7.37 3/31/20224,920,000 shares $34.74 million +11.6%9.8%12.1 $7.06 3/15/20224,410,000 shares $25.00 million +10.3%8.7%9.9 $5.67 2/28/20224,000,000 shares $24.12 million +0.5%7.9%7.6 $6.03 2/15/20223,980,000 shares $23.04 million +14.7%7.9%7.3 $5.79 1/31/20223,470,000 shares $18.67 million +17.2%7.1%6.1 $5.38 1/15/20222,960,000 shares $17.26 million +21.3%N/A0 $5.83 12/31/20212,440,000 shares $17.69 million No Change5.0%4.1 $7.25 HUMA Short Interest - Frequently Asked Questions What is Humacyte's current short interest? Short interest is the volume of Humacyte shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 4,190,000 shares of HUMA short. 4.64% of Humacyte's shares are currently sold short. Learn More on Humacyte's current short interest. What is a good short interest ratio for Humacyte? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HUMA shares currently have a short interest ratio of 2.0. Learn More on Humacyte's short interest ratio. What is a good short interest percentage for Humacyte? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.64% of Humacyte's floating shares are currently sold short. Is Humacyte's short interest increasing or decreasing? Humacyte saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 4,190,000 shares, a decline of 6.7% from the previous total of 4,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Humacyte's float size? Humacyte currently has issued a total of 119,080,000 shares. Some of Humacyte's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Humacyte currently has a public float of 90,320,000 shares. How does Humacyte's short interest compare to its competitors? 4.64% of Humacyte's shares are currently sold short. Here is how the short interest of companies compare to Humacyte: Evolv Technologies Holdings, Inc. (8.91%), Daseke, Inc. (2.18%), BARK, Inc. (15.76%), System1, Inc. (7.04%), The Beachbody Company, Inc. (4.81%), Immunovant, Inc. (15.25%), SpringWorks Therapeutics, Inc. (14.43%), Arcellx, Inc. (9.67%), Apogee Therapeutics, Inc. (12.30%), Denali Therapeutics Inc. (8.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Humacyte stock? Short selling HUMA is an investing strategy that aims to generate trading profit from Humacyte as its price is falling. HUMA shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Humacyte? A short squeeze for Humacyte occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HUMA, which in turn drives the price of the stock up even further. How often is Humacyte's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HUMA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Evolv Technologies Short Interest Data Daseke Short Interest Data BARK Short Interest Data System1 Short Interest Data Beachbody Short Interest Data Immunovant Short Interest Data SpringWorks Therapeutics Short Interest Data Arcellx Short Interest Data Apogee Therapeutics Short Interest Data Denali Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HUMA) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humacyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.